Registration number:
Boss Medical Science Limited
for the Year Ended 31 December 2017
9A Burroughs Gardens
London
NW4 4AU
Boss Medical Science Limited
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Financial Statements |
Boss Medical Science Limited
Company Information
Directors |
Mr R Bessell Mr T R Payne |
Registered office |
|
Registered number |
09787923 |
Accountants |
|
Page 1 |
Boss Medical Science Limited
(Registration number: 09787923)
Balance Sheet as at 31 December 2017
Note |
2017 |
2016 |
|
Current assets |
|||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net assets/(liabilities) |
|
( |
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Profit and loss account |
|
( |
|
Total equity |
|
( |
For the financial year ending 31 December 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
Approved and authorised by the
.........................................
Mr R Bessell
Director
Page 2 |
Boss Medical Science Limited
Notes to the Financial Statements for the Year Ended 31 December 2017
General information |
The company is a private company limited by share capital, incorporated in United Kingdom.
The address of its registered office is:
United Kingdom
The principal place of business is:
101 Lincoln House
1 Brixton Road
Kennington
London
SW9 6DE
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
The accounts have been prepared on a going concern basis on the understanding that the parent company will continue to support the company for the foreseeable future.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for services provided and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Page 3 |
Boss Medical Science Limited
Notes to the Financial Statements for the Year Ended 31 December 2017
Tax
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Debtors |
Note |
2017 |
2016 |
|
Trade debtors |
|
- |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
- |
|
Other debtors |
|
|
|
|
|
Creditors |
Creditors: amounts falling due within one year
Note |
2017 |
2016 |
|
Due within one year |
|||
Trade creditors |
- |
|
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
|
|
|
Taxation and social security |
|
|
|
Other creditors |
|
|
|
|
|
Page 4 |
Boss Medical Science Limited
Notes to the Financial Statements for the Year Ended 31 December 2017
Share capital |
Allotted, called up and fully paid shares
2017 |
2016 |
|||
No. |
£ |
No. |
£ |
|
|
|
100 |
|
100 |
Dividends |
2017 |
2016 |
|||
£ |
£ |
|||
Interim dividend of £
|
10,000 |
- |
||
Ultimate parent company |
The company' s ultimate parent company and controlling party is Boss Professional Services Limited.
Related party disclosures |
Boss Professional Services Limited
Parent company
At the balance sheet date, Boss Professional Services Limited owed £5,697 to the company. (2016: -£22,169)
Boss ERP Consulting Limited
Under common control
At the balance sheet date, the company owed £37,708 (2016: £4,476) to Boss ERP Consulting Limited.
Boss Energy Consulting Ltd
Under common control
At the balance sheet date, the company owed £3,411 (2016: £11,411) to Boss Energy Consulting Ltd.
Smarttek Global Limited
Under common control
At the balance sheet date, Smarttek Global Limited owed £10,000 (2016: £nil) to the company.
Page 5 |